SCHEMBL8345944

SCHEMBL8345944

Cc1cccc(C)c1NC(=O)[C@@H](CC(C)C)NC(=S)Nc1ccc(OCCN(C)C)cc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.43
KMT2A Q03164 6/20 0.43
ALDH1A1 P00352 8/20 0.42
NPSR1 Q6W5P4 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
LMNA P02545 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 6/20 0.41
TP53 P04637 2/20 0.41
HTT P42858 3/20 0.40
ANPEP P15144 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
POLB P06746 2/20 0.40
RECQL P46063 1/20 0.40
NPY1R P25929 1/20 0.40
PKM P14618 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6718999 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6713989 0.90 KMT2A (0.51) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL8346261 0.90 KMT2A (0.51) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6718995 0.88 MEN1 (0.45) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6714162 0.88 MEN1 (0.56) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6714168 0.88 MEN1 (0.56) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6718673 0.86 ALDH1A1 (0.46) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
Hydrochloric Acid SCHEMBL6717144 0.86 ALDH1A1 (0.46) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6717245 0.79 ALDH1A1 (0.49) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2
SCHEMBL6716681 0.76 SMN1; SMN2 (0.55) MEN1KMT2AALDH1A1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004022534-A1 ARYLGLYCINE DERIVATIVES FOR USE AS GLYCINE TRANSPORT INHIBITORS NPS ALLELIX CORP. (CA) 2004-03-18 WO disclosed